The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease

Overview of attention for article published in Frontiers in oncology, February 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 45 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,858 followers.

@m0370 こちらなどいかがでしょうか。 https://t.co/mA5cZ37XFd

05 May 2021

Reply Repost Favourite

New research: The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: Immune checkpoint inhibitor (ICI) is a revolutionary breakthrough in the field of cancer treatment. Because of… https://t.co/E

29 Mar 2021

Reply Repost Favourite

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease https://t.co/CQKXkMFZjp

11 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.